It appears you don't have support to open PDFs in this web browser. To view this file, Open with your PDF reader
Abstract
De novo heterozygous missense variants in the γ-tubulin gene TUBG1 have been linked to human malformations of cortical development associated with intellectual disability and epilepsy. Here, we investigated through in-utero electroporation and in-vivo studies, how four of these variants affect cortical development. We show that TUBG1 mutants affect neuronal positioning, disrupting the locomotion of new-born neurons but without affecting progenitors’ proliferation. We further demonstrate that pathogenic TUBG1 variants are linked to reduced microtubule dynamics but without major structural nor functional centrosome defects in subject-derived fibroblasts. Additionally, we developed a knock-in Tubg1Y92C/+ mouse model and assessed consequences of the mutation. Although centrosomal positioning in bipolar neurons is correct, they fail to initiate locomotion. Furthermore, Tubg1Y92C/+ animals show neuroanatomical and behavioral defects and increased epileptic cortical activity. We show that Tubg1Y92C/+ mice partially mimic the human phenotype and therefore represent a relevant model for further investigations of the physiopathology of cortical malformations.
New mutations and genes associated with malformations of cortical development keep being identified, yet there is little known about the underlying cellular mechanisms controlling these impairments. Here, authors generate and characterize a heterozygous TUBG1 knock-in mouse model bearing one of these known mutations and show that TUBG1 mutation leads to the miss-positioning of neurons in the cortical wall due to migration, because of defective microtubules dynamics, and not proliferation defects during corticogenesis.
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer
Details






1 Institut de Génétique et de Biologie Moléculaire et Cellulaire, Illkirch, France (GRID:grid.420255.4) (ISNI:0000 0004 0638 2716); Centre National de la Recherche Scientifique, UMR7104, Illkirch, France (GRID:grid.4444.0) (ISNI:0000 0001 2112 9282); Institut National de la Santé et de la Recherche Médicale, U1258, Illkirch, France (GRID:grid.457373.1); Université de Strasbourg, Strasbourg, France (GRID:grid.11843.3f) (ISNI:0000 0001 2157 9291)
2 Institute of Molecular Genetics of the Czech Academy of Sciences, Prague, Czech Republic (GRID:grid.418827.0) (ISNI:0000 0004 0620 870X)
3 Institut de Génétique et de Biologie Moléculaire et Cellulaire, Illkirch, France (GRID:grid.420255.4) (ISNI:0000 0004 0638 2716); Centre National de la Recherche Scientifique, UMR7104, Illkirch, France (GRID:grid.4444.0) (ISNI:0000 0001 2112 9282); Institut National de la Santé et de la Recherche Médicale, U1258, Illkirch, France (GRID:grid.457373.1); Université de Strasbourg, Strasbourg, France (GRID:grid.11843.3f) (ISNI:0000 0001 2157 9291); Université de Bourgogne, SVTE, Boulevard Gabriel, Dijon, France (GRID:grid.5613.1) (ISNI:0000 0001 2298 9313)
4 Hôpital Cochin, AP-HP, Service de Biochimie et de Génétique Moléculaire, Paris, France (GRID:grid.411784.f) (ISNI:0000 0001 0274 3893)
5 Institut de Génétique et de Biologie Moléculaire et Cellulaire, Illkirch, France (GRID:grid.420255.4) (ISNI:0000 0004 0638 2716); Centre National de la Recherche Scientifique, UMR7104, Illkirch, France (GRID:grid.4444.0) (ISNI:0000 0001 2112 9282); Université de Strasbourg, Strasbourg, France (GRID:grid.11843.3f) (ISNI:0000 0001 2157 9291)
6 CELPHEDIA, PHENOMIN, Institut Clinique de la Souris (ICS), Illkirch-Graffenstaden, France (GRID:grid.452426.3) (ISNI:0000 0004 0404 8159)
7 Institut de Génétique et de Biologie Moléculaire et Cellulaire, Illkirch, France (GRID:grid.420255.4) (ISNI:0000 0004 0638 2716); Centre National de la Recherche Scientifique, UMR7104, Illkirch, France (GRID:grid.4444.0) (ISNI:0000 0001 2112 9282); Institut National de la Santé et de la Recherche Médicale, U1258, Illkirch, France (GRID:grid.457373.1); Université de Strasbourg, Strasbourg, France (GRID:grid.11843.3f) (ISNI:0000 0001 2157 9291); Université de Strasbourg, Fédération de Médecine Translationnelle de Strasbourg, Strasbourg, France (GRID:grid.11843.3f) (ISNI:0000 0001 2157 9291); Hôpitaux Universitaire de Strasbourg, Laboratoire de Diagnostic Génétique, Strasbourg, France (GRID:grid.412220.7) (ISNI:0000 0001 2177 138X)